FDA approves SC isatuximab-irfc with the CirCLIQ on-body injector, streamlining multiple myeloma care and reducing nursing burden.
Sikander Ailawadhi, MD
Advertisement
Articles by Sikander Ailawadhi, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
WHO Report: Global Cancer Cases to Double by 2050; Nurses Must Act
2
FDA Approves First On-Body Injector for Multiple Myeloma Treatment
3
FDA Approves Subcutaneous Isatuximab-irfc for Multiple Myeloma
4
FDA Expands Pembrolizumab Label for Muscle-Invasive Bladder Cancer
5